A detailed history of Brandywine Global Investment Management, LLC transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Brandywine Global Investment Management, LLC holds 100,899 shares of ANIP stock, worth $5.69 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
100,899
Previous 107,310 5.97%
Holding current value
$5.69 Million
Previous $6.83 Million 11.91%
% of portfolio
0.04%
Previous 0.05%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$54.33 - $65.72 $348,309 - $421,330
-6,411 Reduced 5.97%
100,899 $6.02 Million
Q2 2024

Aug 14, 2024

SELL
$58.53 - $68.82 $454,251 - $534,112
-7,761 Reduced 6.74%
107,310 $6.83 Million
Q1 2024

May 13, 2024

SELL
$54.2 - $69.69 $994,515 - $1.28 Million
-18,349 Reduced 13.75%
115,071 $7.95 Million
Q4 2023

Feb 09, 2024

BUY
$48.72 - $65.43 $20,706 - $27,807
425 Added 0.32%
133,420 $7.36 Million
Q3 2023

Nov 13, 2023

SELL
$50.28 - $64.61 $79,241 - $101,825
-1,576 Reduced 1.17%
132,995 $7.72 Million
Q2 2023

Aug 11, 2023

BUY
$37.29 - $53.83 $175,934 - $253,969
4,718 Added 3.63%
134,571 $7.24 Million
Q1 2023

May 12, 2023

BUY
$37.61 - $45.72 $82,177 - $99,898
2,185 Added 1.71%
129,853 $5.16 Million
Q4 2022

Feb 10, 2023

BUY
$31.9 - $41.95 $572,062 - $752,289
17,933 Added 16.34%
127,668 $5.14 Million
Q3 2022

Nov 14, 2022

BUY
$29.83 - $38.01 $660,376 - $841,465
22,138 Added 25.27%
109,735 $3.53 Million
Q2 2022

Aug 11, 2022

SELL
$23.09 - $33.46 $218,593 - $316,765
-9,467 Reduced 9.75%
87,597 $2.6 Million
Q1 2022

May 13, 2022

SELL
$26.91 - $47.15 $807 - $1,414
-30 Reduced 0.03%
97,064 $2.73 Million
Q4 2021

Feb 11, 2022

BUY
$32.97 - $56.85 $2.76 Million - $4.76 Million
83,754 Added 627.84%
97,094 $4.47 Million
Q3 2021

Nov 12, 2021

SELL
$26.48 - $35.99 $5,296 - $7,198
-200 Reduced 1.48%
13,340 $438,000
Q2 2021

Aug 13, 2021

SELL
$31.86 - $38.6 $35,046 - $42,460
-1,100 Reduced 7.51%
13,540 $475,000
Q1 2021

May 13, 2021

SELL
$28.4 - $36.14 $5,680 - $7,228
-200 Reduced 1.35%
14,640 $529,000
Q4 2020

Feb 10, 2021

BUY
$23.69 - $31.47 $3,885 - $5,161
164 Added 1.12%
14,840 $431,000
Q3 2020

Nov 12, 2020

BUY
$26.38 - $33.1 $58,036 - $72,820
2,200 Added 17.63%
14,676 $415,000
Q2 2020

Aug 14, 2020

BUY
$29.93 - $50.1 $5,986 - $10,020
200 Added 1.63%
12,476 $404,000
Q1 2020

May 15, 2020

BUY
$30.35 - $67.14 $2,670 - $5,908
88 Added 0.72%
12,276 $501,000
Q4 2019

Feb 14, 2020

BUY
$55.65 - $79.83 $144,022 - $206,600
2,588 Added 26.96%
12,188 $733,000
Q2 2019

Aug 14, 2019

BUY
$67.77 - $82.2 $460,836 - $558,960
6,800 Added 242.86%
9,600 $790,000
Q1 2019

May 15, 2019

BUY
$45.83 - $70.54 $128,324 - $197,512
2,800 New
2,800 $198,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $982M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Brandywine Global Investment Management, LLC Portfolio

Follow Brandywine Global Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brandywine Global Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brandywine Global Investment Management, LLC with notifications on news.